| Financial Year |
March 31 2023 |
| Monetary Funds |
155,115,961.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,818,849.33 |
| Accounts Receivable |
652,207,895.87 |
| Advances to Suppliers |
39,571,397.80 |
| Other Receivables |
13,634,843.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
447,741,556.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,021,345.49 |
| Total Current Assets |
1,334,202,584.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
28,178,494.03 |
| Long-term Equity Investment |
64,270,275.44 |
| Investment Properties |
5,254,933.29 |
| Fixed Assetes |
348,943,092.50 |
| Under-construction Projects |
11,426,731.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,431,208.79 |
| R&D expenses |
12,200,274.15 |
| Goodwill |
36,682,318.97 |
| Long-Term Deferred and Prepaid Expenses |
884,388.84 |
| Deferred Income Tax Assets |
49,510,832.79 |
| Other Non-Current Assets |
9,192,806.70 |
| Sub-Total of Non-Current Assets |
841,268,251.30 |
| Total Assets |
2,175,470,835.78 |
| Short-Term Loans |
333,375,336.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,275,679.89 |
| Accounts Payable |
293,869,982.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,432,486.42 |
| Taxes Payable |
77,655,644.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,973,917.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,703,141.03 |
| Other Current Liabilities |
4,166,538.78 |
| Sub-Total of Current Liabilities |
946,892,516.56 |
| Long-term Loans |
131,063,692.91 |
| Bonds Payable |
224,146,639.86 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,984,600.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
464,278,336.00 |
| Total Liabilities |
1,411,170,852.56 |
| Paid-In Capital(Or Share Stock) |
239,893,853.00 |
| Capital Surplus |
213,858,509.00 |
| Surplus Reserve |
47,950,220.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
205,848,802.43 |
| Minority Stockholder's Interest |
11,443,250.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
752,856,732.62 |
| Owner's Equity（Stockholder's Equity） |
764,299,983.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,175,470,835.78 |
